5:47 PM
 | 
Oct 12, 2006
 |  BC Extra  |  Company News

FDA wants another Saforis trial

MGI Pharma (MOGN) said it received an approvable letter from FDA for Saforis oral suspension to treat and prevent oral...

Read the full 85 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >